Spark Therapeutics’s success is lifting all gene therapy stocks even though risks remain – STAT (blog)
Cosmos (blog) |
Spark Therapeutics's success is lifting all gene therapy stocks even though risks remain
STAT (blog) he stock prices of companies developing gene therapies are surging on optimism that one-shot treatments will cure a host of rare, inherited diseases, so let's take a moment to remember gene therapy is risky and prone to failure. At an FDA advisory … Gene therapy for blindness heading for approval | Cosmos New gene therapy gives hope to people born with inherited eye … FDA advisory committee vote 16-0 for first even gene therapy for … |
